IHS Chemical Week

Chemical Week Magazine :: Pharmaceuticals & Fine Chemicals

Mylan Completes Acquisition of Merck’s Generics Business

2:17 PM MDT | October 15, 2007 | Chemical Week Editorial Staff

Mylan Laboratories (Canonsburg, PA) has completed the previously announced acquisition of Merck KGaA’s generic drugs business for €4.9 billion ($6.7 billion) in cash. The companies signed a definitive agreement for the deal in May (CW, May 23, p. 25). Merck’s generics business generated sales of €1.8 billion in 2006 and has about 5,000 employees. Merck previously announced that it intends to use proceeds from the sale to pay down debt. Mylan has acquired all of Merck’s generics subsidiaries worldwide, and the deal positions Mylan as...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Risk Free Trial

Email Address

First Name

Last Name

Click here to register and get your RISK-FREE access to chemweek.com

Not an IHS Chemical Week
24/7 member yet?

Here's why you should be:

  • Searchable online archive access of the last 2 years of Chemical Week.
  • Print or digital magazine subscription
  • Price and market change alerts
  • Economic data and statistics
  • Buyers' Guides
  • Webcasts | whitepapers




contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa